ProPhase Labs
PRPH
PRPH was delisted on the 2nd of January, 2026.
37 hedge funds and large institutions have $2.02M invested in ProPhase Labs in 2025 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 5 closing their positions.
140% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 5
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
23% more funds holding
Funds holding: 30 → 37 (+7)
5% more capital invested
Capital invested by funds: $1.91M → $2.02M (+$104K)
0.66% more ownership
Funds ownership: 1.01% → 1.67% (+0.66%)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WC
Wexford Capital
West Palm Beach,
Florida
|
+$700K |
| 2 |
FCM
FourWorld Capital Management
New York
|
+$173K |
| 3 |
QOP
Quinn Opportunity Partners
Charlottesville,
Virginia
|
+$146K |
| 4 |
CFG
Citizens Financial Group
Providence,
Rhode Island
|
+$124K |
| 5 |
JAIC
Josh Arnold Investment Consultant
Edina,
Minnesota
|
+$115K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$113K |
| 2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$77K |
| 3 |
Squarepoint
New York
|
-$39.7K |
| 4 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
-$18.4K |
| 5 |
EGM
Engineers Gate Manager
New York
|
-$12.1K |
PRPH Hedge Fund Activity: Q1 2025 in Review
37 of the 7,469 institutional investors tracked by Wall St. Rank reported a position in ProPhase Labs (PRPH) for Q1 2025, worth a combined $2.02M — up 5.4% from $1.91M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new PRPH positions and 5 closed out — a net gain of 7 holders — while 8 added to existing stakes and 6 trimmed.
The largest buyer was Wexford Capital, opening a new position worth an estimated $700K. The largest seller was Vanguard Group, cutting an estimated $113K.
- 37 institutional investors held ProPhase Labs (PRPH) as of Q1 2025, up from 30 in Q4 2024.
- Funds reported $2.02M of ProPhase Labs stock for Q1 2025, up 5.4% quarter-over-quarter.
- 12 funds opened new ProPhase Labs positions in Q1 2025 and 5 closed out, a net change of +7 holders.
- The largest ProPhase Labs buyer in Q1 2025 was Wexford Capital, an estimated $700K added.
- The largest ProPhase Labs seller in Q1 2025 was Vanguard Group, an estimated $113K sold.
Based on aggregated 13F filings for Q1 2025.